Akums Drugs & Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Akums Drugs & Pharma	Sudeep Pharma	Aarti Pharmalabs
Operational Metrics
Pharmaceuticals
DMF Filingsby API	20.0 .	n/a	n/a
R&D as a % of Total Sales	0.7 %	2.06 %	n/a
Financials
5 yr Average ROE	-0.59 %	30.67 %	9.05 %
5yr average Equity Multiplier	3.58	1.75	1.39
5yr Average Asset Turnover Ratio	1.18	0.92	0.58
5yr Avg Net Profit Margin	1.67 %	20.26 %	8.95 %
Price to Book	2.24	9.7	3.29
P/E	22.23	50.68	28.06
5yr Avg Cash Conversion Cycle	41.09 Days	57.48 Days	94.46 Days
Inventory Days	60.56 Days	44.61 Days	94.9 Days
Days Receivable	71.09 Days	119.94 Days	94.46 Days
Days Payable	82.93 Days	85.02 Days	76.47 Days
5yr Average Interest Coverage Ratio	6.25	33.52	12.05
5yr Avg ROCE	6.7 %	37.68 %	12.13 %
5yr Avg Operating Profit Margin	6.07 %	27.79 %	15.5 %
5 yr average Debt to Equity	0.43	0.33	0.16
5yr CAGR Net Profit	22.48 %	32.99 %	n/a
5yr Average Return on Assets	1.78 %	18.08 %	6.11 %
Shareholdings
Promoter Holding	75.26 %	76.15 %	42.88 %
Share Pledged by Promoters	0.0	0.0	0.01 %
Change in Promoter Holding (3 Yrs)	0.0	-23.85 %	-3.1 %
Change in Mutual Fund Holding (3 Yrs)	1.26 %	3.44 %	-4.32 %

	Akums Drugs & Pharma	Sudeep Pharma	Aarti Pharmalabs
Product Wise Break-Up	Product Wise Break-Up CDMO 78.18 Branded and generic formulations 16.74 API 5.09 Xanthine derivatives & Intermediates 0 API and Intermediates 0 CMO/CDMO 0	-	Product Wise Break-Up API 0 API 39.4 Branded and generic formulations 0 CDMO 0 CDMO 9.7 Xanthine 50.9
Location Wise Break-Up	Location Wise Break-Up India 93.55 Outside India 6.45 North America 0 Middle East & Africa 0 Europe 0 Asia Pacific 0	Location Wise Break-Up Asia Pacific 13.87 India 41.32 Europe 17.46 Middle East & Africa 8.08 North America 15.92 Outside India 0 Others 3.35	Location Wise Break-Up Asia Pacific 0 India 47.0 Europe 0 Middle East & Africa 0 North America 0 Outside India 0 Others 53.0
Operating Profit Break-Up	Operating Profit Break-Up CDMO 88.08 Branded and generic formulations 11.92 API`s 0 Speciality ingredients 0 Pharmaceutical, food and nutrition 0	Operating Profit Break-Up Pharmaceutical, food and nutrition 61.34 Branded and generic formulations 0 CDMO 0 Speciality ingredients 38.66 API`s 0	-
Asset Break-Up - Segment Wise	Asset Break-Up - Segment Wise CDMO 76.41 API`s 14.71 Branded and generic formulations 8.88 Speciality ingredients 0 Pharmaceutical, food and nutrition 0	Asset Break-Up - Segment Wise Pharmaceutical, food and nutrition 17.58 Branded and generic formulations 0 CDMO 0 Speciality ingredients 82.42 API`s 0	-